XERS - Xeris Pharmaceuticals Inc - SEC Form 4 Insider Trading Screener

Manufactured Goods - Chemicals - Pharmaceutical Preparations - XERS (1346302)
General
Tickers
Insider
Sh Price $
Lqdty M$
Date
Filing Date
  
Trade Date
  
Filing Delay
N Days Ago
Transaction Filing
P - Purchase
S - Sale
A - Grant
D - Sale to Iss
G - Gift
F - Tax
M - Option Ex
X - Option Ex
C - Cnv Deriv
W - Inherited
No deriv Multiple Days
Traded K$
Own Chg %
Industry
Insider Title   Officer
    COB
    CEO
    Pres
    COO
    CFO
    GC
    VP
  Director
  10% Own
  Other
Group by
Sort by
Max Results
Page
clear
Real-time CSV, Options, Alerts
24 results - Yahoo - Finviz - Stockcharts - Tradingview - Stocktwits - SEC
TCcnt1d1w1m6m

X

Filing Date

Trade Date

Ticker

Insider Name

Insider Title

Trade Type 

Price

Qty

Owned

ΔOwn

Value

1d

1w

1m

6m

2020-05-13
XERSShannon John Patrick JrSee RemarksP - Purchase$3.55+22,000117,493+23%+$77,994
2020-05-08
XERSShannon John Patrick JrSee RemarksP - Purchase$3.20+7,88695,493+9%+$25,219
2020-05-08
XERSEdick Paul RSee RemarksP - Purchase$3.00+33,000414,564+9%+$99,000
2020-03-13
XERSHecht BethSee RemarksP - Purchase$1.97+4,00057,083+8%+$7,880
2020-02-14
XERSShannon John Patrick JrSee RemarksP - Purchase$4.15+12,04822,607+114%+$49,999
2020-02-14
XERSHecht BethSee RemarksP - Purchase$4.15+4,0008,083+98%+$16,600
2020-02-14
XERSEdick Paul RSee RemarksP - Purchase$4.15+20,000196,564+11%+$83,000
2020-02-14
XERSJohnson Kenneth ErlandSee RemarksP - Purchase$4.15+2,4106,115+65%+$10,002
2020-02-14
XERSDeutsch Barry M.See RemarksP - Purchase$4.15+9,63939,359+32%+$40,002
2020-01-13
XERSPrestrelski StevenChief Scientific OfficerS - Sale$5.50-10,000421,824-2%-$54,992
2019-11-25
XERSEdick Paul RSee RemarksP - Purchase$8.55+17,935186,365+11%+$153,283
M
2019-01-14
XERSPrestrelski StevenChief Scientific OfficerS - Sale$12.01-27,700449,324-6%-$332,600
2019-04-11
XERSPrestrelski StevenChief Scientific OfficerS - Sale$9.56-10,000477,024-2%-$95,649
2019-03-11
XERSEdick Paul RSee RemarksP - Purchase$9.12+30,000168,430+22%+$273,585
2019-02-19
XERSJohnson Kenneth ErlandSee RemarksP - Purchase$10.00+1,0003,245+45%+$10,000
2019-02-19
XERSDeutsch Barry M.See RemarksP - Purchase$10.00+5,00028,292+21%+$50,000
2019-02-19
XERSHecht BethSee RemarksP - Purchase$10.00+2,5002,500New+$25,000
2019-02-19
XERSRedmile Group, LLC10%P - Purchase$10.00+588,0003,000,642+24%+$5,880,000
M
2019-02-08
XERSFlynn James EPossible Member of 10% Group, 10%S - Sale$15.09-7,2412,355,1360%-$109,251
M
2019-02-05
XERSFlynn James EPossible Member of 10% Group, 10%S - Sale$15.02-14,8072,362,377-1%-$222,443
M
2019-01-28
XERSFlynn James EPossible Member of 10% Group, 10%S - Sale$15.12-7,0382,377,1840%-$106,448
M
2019-01-23
XERSFlynn James EPossible Member of 10% Group, 10%S - Sale$15.43-114,4442,384,222-5%-$1,766,193
2019-01-11
XERSPrestrelski StevenChief Scientific OfficerS - Sale$0.00-2,300487,0240%-$0
D
2018-12-26
XERSPrestrelski StevenChief Scientific OfficerS - Sale+OE$15.82-15,720489,324-3%-$248,738
AAmended filing
DDerivative transaction in filing (usually option exercise)
EError detected in filing
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top